Adverse Cardiovascular Effects of Anti-COVID-19 Drugs

Dongling Liu, Xiang Zeng, Zufeng Ding, Fenghua Lv, Jawahar L. Mehta, Xianwei Wang

Open source

DOI: 10.3389/fphar.2021.699949
Published: 2021-08-25
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2021.699949,
  title = {Adverse Cardiovascular Effects of Anti-COVID-19 Drugs},
  author = {Dongling Liu and Xiang Zeng and Zufeng Ding and Fenghua Lv and Jawahar L. Mehta and Xianwei Wang},
  year = {2021},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2021.699949},
  url = {https://doi.org/10.3389/fphar.2021.699949}
}

RIS

TY  - JOUR
TI  - Adverse Cardiovascular Effects of Anti-COVID-19 Drugs
AU  - Dongling Liu
AU  - Xiang Zeng
AU  - Zufeng Ding
AU  - Fenghua Lv
AU  - Jawahar L. Mehta
AU  - Xianwei Wang
PY  - 2021
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2021.699949
UR  - https://doi.org/10.3389/fphar.2021.699949
ER  -

APA

Liu, D., Zeng, X., Ding, Z., Lv, F., Mehta, J. L., & Wang, X. (2021). Adverse Cardiovascular Effects of Anti-COVID-19 Drugs. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2021.699949

Source records

crossref · retrieved 2026-09-26T10:07:14.080Z